123 related articles for article (PubMed ID: 8264890)
1. Intracerebral hematoma related to thrombolysis for myocardial infarction.
Kaufman HH; McAllister P; Taylor H; Schmidt S
Neurosurgery; 1993 Nov; 33(5):898-900; discussion 900-1. PubMed ID: 8264890
[TBL] [Abstract][Full Text] [Related]
2. Intracerebral hemorrhage after combined anticoagulant-thrombolytic therapy for myocardial infarction: two case reports and a short review.
Da Silva VF; Bormanis J
Neurosurgery; 1992 Jun; 30(6):943-5. PubMed ID: 1614602
[TBL] [Abstract][Full Text] [Related]
3. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
Gore JM; Sloan M; Price TR; Randall AM; Bovill E; Collen D; Forman S; Knatterud GL; Sopko G; Terrin ML
Circulation; 1991 Feb; 83(2):448-59. PubMed ID: 1899364
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.
Sloan MA; Price TR; Petito CK; Randall AM; Solomon RE; Terrin ML; Gore J; Collen D; Kleiman N; Feit F
Neurology; 1995 Apr; 45(4):649-58. PubMed ID: 7723950
[TBL] [Abstract][Full Text] [Related]
5. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis.
Kase CS; O'Neal AM; Fisher M; Girgis GN; Ordia JI
Ann Intern Med; 1990 Jan; 112(1):17-21. PubMed ID: 2104561
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous suprachoroidal hemorrhage secondary to thrombolysis for the treatment of myocardial infarction.
Barsam A; Heatley CJ; Herbert L
Clin Exp Ophthalmol; 2006 Mar; 34(2):177-9. PubMed ID: 16626438
[TBL] [Abstract][Full Text] [Related]
7. [Intracranial hemorrhage following second thrombolytic treatment of myocardial reinfarction].
Valentín Segura V; Valls Grima F; Broch Porcar MJ; Miralles Serrano L; Olivares Toledo D; Alvarez Cebrián F
Rev Esp Cardiol; 1994 Dec; 47(12):836-8. PubMed ID: 7855379
[TBL] [Abstract][Full Text] [Related]
8. Intracerebral hemorrhage complicating intravenous tissue plasminogen activator treatment.
Carlson SE; Aldrich MS; Greenberg HS; Topol EJ
Arch Neurol; 1988 Oct; 45(10):1070-3. PubMed ID: 3140769
[TBL] [Abstract][Full Text] [Related]
9. Emergency Free-Hand Bedside Catheter Evacuation of Large Intracerebral Hematomas Following Thrombolysis for Ischemic Stroke: A Case Series.
Bardutzky J; Shah M; Lambeck J; Meckel S; Niesen WD
Neurocrit Care; 2020 Aug; 33(1):207-217. PubMed ID: 31797279
[TBL] [Abstract][Full Text] [Related]
10. Haemorrhagic aspects of thrombolytic therapy.
Samama M
Eur Heart J; 1990 Aug; 11 Suppl F():15-8. PubMed ID: 2121488
[No Abstract] [Full Text] [Related]
11. Intracerebral hemorrhage after thrombolytic therapy managed with ventricular drainage.
Al-Khawaja D; Eslick GD; Fuller SJ; Seex K
J Clin Neurosci; 2007 Sep; 14(9):898-900. PubMed ID: 17660059
[TBL] [Abstract][Full Text] [Related]
12. Intraventricular bleeding after the use of thrombolytics in a cocaine user.
LoVecchio F; Nelson L
Am J Emerg Med; 1996 Nov; 14(7):663-4. PubMed ID: 8906766
[TBL] [Abstract][Full Text] [Related]
13. Mental Dullness after thrombolytic therapy.
Woo KS; Chan HC; Poon WS
Postgrad Med J; 1997 Jun; 73(860):347-9. PubMed ID: 9246336
[No Abstract] [Full Text] [Related]
14. Haematoma of the hand as a complication of thrombolysis for myocardial infarction.
Ahmed K; Yavari A; Walker DM; Buchanan JA
J Hand Surg Eur Vol; 2007 Dec; 32(6):720-1. PubMed ID: 17993444
[No Abstract] [Full Text] [Related]
15. Pitfalls of thrombolytic therapy for myocardial infarction.
Ceola WM; Harik SI
J Ark Med Soc; 1998 Jul; 95(2):73-4. PubMed ID: 9676061
[No Abstract] [Full Text] [Related]
16. Paraplegia subsequent to administration of tissue plasminogen activator and intravenous heparin following myocardial infarction--a case report.
DePorto R; Ahn JH; Gianutsos JG
J Spinal Cord Med; 2000; 23(2):150-2. PubMed ID: 10914357
[TBL] [Abstract][Full Text] [Related]
17. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.
Gurwitz JH; Gore JM; Goldberg RJ; Barron HV; Breen T; Rundle AC; Sloan MA; French W; Rogers WJ
Ann Intern Med; 1998 Oct; 129(8):597-604. PubMed ID: 9786806
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
19. Fatal intracerebral hemorrhage following thrombolytic therapy of embolic myocardial infarction in unsuspected infective endocarditis.
Di Salvo TG; Tatter SB; O'Gara PT; Nielsen GP; DeSanctis RW
Clin Cardiol; 1994 Jun; 17(6):340-4. PubMed ID: 8070153
[TBL] [Abstract][Full Text] [Related]
20. Thrombolytic therapy for coronary occlusion.
Thompson PL
Med J Aust; 1992 Jul; 157(2):75-7. PubMed ID: 1630392
[No Abstract] [Full Text] [Related]
[Next] [New Search]
